Identification of inflammatory and vascular markers associated with mild cognitive impairment
- 30 April 2019
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 11 (8) , 2403-2419
Abstract
Biochemical processes have been associated with the pathogenesis of mild cognitive impairment (MCI) and dementia, including chronic inflammation, dysregulation of membrane lipids and disruption of neurotransmitter pathways. However, research investigating biomarkers of these processes in MCI remained sparse and inconsistent. To collect fresh evidence, we evaluated the performance of several potential markers in a cohort of 57 MCI patients and 57 cognitively healthy controls. MCI patients showed obviously increased levels of plasma TNF-α (p = 0.045) and C-peptide (p = 0.004) as well as decreased levels of VEGF-A (p = 0.042) and PAI-1 (p = 0.019), compared with controls. In addition, our study detected significant correlations of plasma sTNFR-1 (MCI + Control: B = -6.529, p = 0.020; MCI: B = -9.865, p = 0.011) and sIL-2Rα (MCI + Control: B = -7.010, p = 0.007; MCI: B = -11.834, p = 0.003) levels with MoCA scores in the whole cohort and the MCI group. These findings corroborate the inflammatory and vascular hypothesis for dementia. Future studies are warranted to determine their potential as early biomarkers for cognitive deficits and explore the related mechanisms.Keywords
This publication has 47 references indexed in Scilit:
- High performance plasma amyloid-β biomarkers for Alzheimer’s diseaseNature, 2018
- Practice guideline update summary: Mild cognitive impairment [RETIRED]Neurology, 2018
- Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studiesJournal of Neurology, Neurosurgery & Psychiatry, 2017
- Role of metabolism in neurodegenerative disordersMetabolism, 2016
- Clinical Characteristics for the Relationship between Type-2 Diabetes Mellitus and Cognitive Impairment: A Cross-Sectional StudyAging and disease, 2015
- Brain metabolic dysfunction at the core of Alzheimer's diseaseBiochemical Pharmacology, 2014
- Mild cognitive impairment: a concept in evolutionJournal of Internal Medicine, 2014
- Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: A cross–section studyAnnales d'Endocrinologie, 2012
- Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairmentNeurobiology of Aging, 2010
- Inflammatory markers and the risk of Alzheimer diseaseNeurology, 2007